# Intranasal Ketamine as a Sedative for Venipuncture

> **NCT02929524** · PHASE2,PHASE3 · COMPLETED · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 39 (actual)

## Conditions studied

- Respiratory Tract Disease
- Acute Pain
- Diseases of the Digestive System

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02929524
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2016-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929524, "Intranasal Ketamine as a Sedative for Venipuncture". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02929524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*